IMD-0354 (Standard)
IMD-0354 (Standard) is the analytical standard of IMD-0354. This product is intended for research and analytical applications. IMD-0354 (IKK2 Inhibitor V) is a selective IKKβ inhibitor which inhibits NF-κB activity. IMD0354 inhibits TNF-α induced NF-κB transcription activity with an IC50 of 1.2 uM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98%
- No. CAS: 978-62-1
- Fòrmula: C15H8ClF6NO2
- Peso molecular:383.67
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-10172
IMD-0354IKKβ Inhibitor -
HY-10518
BMS-345541 hydrochlorideIKK-1/IKK-2 Inhibitor -
HY-10519
BMS-345541IKK-1/IKK-2 Inhibitor -
HY-15473
MLN120BIKKβ Inhibitor -
HY-10074
TPCA-1IKK-2 Inhibitor -
HY-B0713
AmlexanoxIKK Inhibitor -
HY-13802
SC-514IKK Inhibitor -
HY-12453
TBK1/IKKε-IN-2TBK1/IKKε Inhibitor -
HY-13453
BAY 11-7082IκBα/NF-κB Inhibitor -
HY-13687
IKK 16IKK Inhibitor -
HY-N0551
WedelolactoneCaspase-11 And 5-Lox Inhibitor -
HY-13060
ACHP HydrochlorideIKKβ Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 978-62-1
-
Peso molecular 383.67
-
Fòrmula C15H8ClF6NO2
-
SMILES
O=C(NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)C2=CC(Cl)=CC=C2O
-
Synonyms
IKK2 Inhibitor V (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Tanaka A, et al. A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood. 2005 Mar 15;105(6):2324-31. [Content Brief]
[2]. Li YR, et al. Study of the inhibitory effects on TNF-α-induced NF-κB activation of IMD0354 analogs. Chem Biol Drug Des. 2017 Dec;90(6):1307-1311. [Content Brief]
[3]. Tanaka A, et al. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition. Cancer Res. 2006 Jan 1;66(1):419-26. [Content Brief]
[4]. Lennikov A, et al. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012;18:2586-97. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
IMD-0354 (Standard) Related Classifications
HY-10172R Related Classifications
Powered by Bioz